Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

Clayton Moorse's parents couldn't slip a T-shirt over his torso because of his distended stomach. Tests revealed the toddler ...

Penn cell therapy spinout Verismo Therapeutics has a new owner. Here's how the deal came together and why everyone is telling ...

Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer.

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.